Nuvectis Pharma Inc. (NVCT)
NASDAQ: NVCT
· Real-Time Price · USD
9.02
-0.39 (-4.14%)
At close: Jun 02, 2025, 3:59 PM
-4.14% (1D)
| Bid | 8.5 |
| Market Cap | 188.46M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -20.16M |
| EPS (ttm) | -1.13 |
| PE Ratio (ttm) | -7.98 |
| Forward PE | -8.79 |
| Analyst | Buy |
| Ask | 9.7 |
| Volume | 139,974 |
| Avg. Volume (20D) | 135,687 |
| Open | 9.73 |
| Previous Close | 9.41 |
| Day's Range | 8.93 - 9.74 |
| 52-Week Range | 4.44 - 11.80 |
| Beta | -0.12 |
About NVCT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NVCT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NVCT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
-46.3%
Nuvectis Pharma shares are trading lower. The comp...
Unlock content with
Pro Subscription
6 months ago
+17.75%
Nuvectis Pharma shares are trading higher after the company reported better-than-expected Q3 EPS results.
